Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
9.41
-0.20 (-2.08%)
Jan 21, 2026, 4:00 PM EST - Market closed
Sensei Biotherapeutics Market Cap
Sensei Biotherapeutics has a market cap or net worth of $11.87 million as of January 22, 2026. Its market cap has decreased by -8.37% in one year.
Market Cap
11.87M
Enterprise Value
-11.15M
1-Year Change
-8.37%
Ranking
Category
Stock Price
$9.41
Market Cap Chart
Since the IPO on February 4, 2021, Sensei Biotherapeutics's market cap has decreased from $561.61M to $11.87M, a decrease of -97.89%. That is a compound annual growth rate of -54.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 11.87M | -11.81% |
| Dec 31, 2025 | 13.46M | 9.18% |
| Dec 31, 2024 | 12.33M | -28.74% |
| Dec 29, 2023 | 17.30M | -62.21% |
| Dec 30, 2022 | 45.77M | -74.21% |
| Dec 31, 2021 | 177.46M | -68.40% |
| Feb 4, 2021 | 561.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tempest Therapeutics | 12.71M |
| Curis | 12.52M |
| BioLineRx | 12.38M |
| Edesa Biotech | 12.17M |
| CytoMed Therapeutics | 12.12M |
| Akari Therapeutics, | 12.08M |
| Bolt Biotherapeutics | 12.05M |
| Imunon | 11.77M |